fda approved glp 1 agonists Benefits and Risks of GLP-1 Receptor Outlined The Impact of GLP-1 Receptor

Study methods: Adult patients who were taking GLP-1s and scheduled to receive anesthesia at 3 hospitals between June 30, 2023, and August 15, 2024, were evaluated via preoperative point-of-care gastric ultrasonography (GUS)

GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid

There is less known about tirzepatide (Mounjaro, Zepbound) because it is a relatively member of this drug family

Compounded versions of both are available through telehealth providers and compounding pharmacies with a prescription

But tens of thousands of people have studied these proteins and made new and better versions

Still in Phase 3 clinical trials, early results show unprecedented weight loss, with some participants losing over 24 percent of body weight